Altria: Revenue and Profit Challenges Amid Nicotine Pouch Surge

Market Performance and Strategic Shifts

Altria, the renowned tobacco giant and owner of Marlboro, has recently demonstrated resilience despite facing declining revenues. The company's second-quarter revenue dropped by 1.7% to $6.1 billion. However, this figure surpassed analyst expectations, which had projected revenues of $5.18 billion. This performance has allowed Altria to adjust its earnings outlook positively, despite the ongoing challenges in traditional cigarette sales. The company's net profit fell to $2.38 billion from $3.8 billion in the same quarter last year. Yet, the adjusted earnings per share came in at $1.44, exceeding the forecasted $1.39. Consequently, Altria's stock responded favorably, with a nearly 3% increase at the start of trading in the US.

Focus on Alternatives and Market Dynamics

Amid a backdrop of declining traditional tobacco sales, which fell over 10%, Altria is pivoting towards alternative products such as vaping devices and nicotine pouches. The sales of Altria's nicotine pouches, branded as on!, surged by 26.5% in the second quarter, proving a significant growth area for the company. This spike in demand has helped offset the setbacks from a halted vape product line, NJOY, due to patent issues. Altria has raised the lower end of its annual earnings forecast, now expecting a profit of $5.35 to $5.45 per share for 2025. This optimism contrasts with competitor Philip Morris International, which recently reported disappointing figures for its Zyn nicotine pouches. Altria's strategic focus on diversifying its product offerings appears to be paying off, as it remains confident about continued growth in its alternative product lines.

Investor Outlook and Stock Movement

At the time of reporting, Altria Group's shares were trading at €53.20 on Tradegate, marking a 3.54% increase. Analysts have set a price target of €56.06, suggesting a potential upside of 5% from the current trading levels. Investors are encouraged to consider the company's strategic pivot and the growing market for alternative nicotine products as key factors in its future performance. Despite challenges, Altria's adaptability and focus on innovation in the face of declining traditional cigarette sales emphasize its commitment to maximizing shareholder value. As the company continues to expand its alternative nicotine product portfolio, it positions itself as a robust player in the evolving tobacco industry landscape.